Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.

Condition:   Ototoxic Hearing Loss Intervention:   Drug: N-Acetyl Cysteine Sponsors:   Sunnybrook Health Sciences Centre;   Toronto Sunnybrook Regional Cancer Centre;   London Regional Cancer Program, Canada Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials